BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 30367465)

  • 1. Loss or oncogenic mutation of DROSHA impairs kidney development and function, but is not sufficient for Wilms tumor formation.
    Kruber P; Angay O; Winkler A; Bösl MR; Kneitz S; Heinze KG; Gessler M
    Int J Cancer; 2019 Mar; 144(6):1391-1400. PubMed ID: 30367465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent somatic mutation in DROSHA induces microRNA profile changes in Wilms tumour.
    Torrezan GT; Ferreira EN; Nakahata AM; Barros BD; Castro MT; Correa BR; Krepischi AC; Olivieri EH; Cunha IW; Tabori U; Grundy PE; Costa CM; de Camargo B; Galante PA; Carraro DM
    Nat Commun; 2014 Jun; 5():4039. PubMed ID: 24909261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The DGCR8 E518K mutation found in Wilms tumors leads to a partial miRNA processing defect that alters gene expression patterns and biological processes.
    Vardapour R; Kehl T; Kneitz S; Ludwig N; Meese E; Lenhof HP; Gessler M
    Carcinogenesis; 2022 Mar; 43(2):82-93. PubMed ID: 34919667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in the SIX1/2 pathway and the DROSHA/DGCR8 miRNA microprocessor complex underlie high-risk blastemal type Wilms tumors.
    Wegert J; Ishaque N; Vardapour R; Geörg C; Gu Z; Bieg M; Ziegler B; Bausenwein S; Nourkami N; Ludwig N; Keller A; Grimm C; Kneitz S; Williams RD; Chagtai T; Pritchard-Jones K; van Sluis P; Volckmann R; Koster J; Versteeg R; Acha T; O'Sullivan MJ; Bode PK; Niggli F; Tytgat GA; van Tinteren H; van den Heuvel-Eibrink MM; Meese E; Vokuhl C; Leuschner I; Graf N; Eils R; Pfister SM; Kool M; Gessler M
    Cancer Cell; 2015 Feb; 27(2):298-311. PubMed ID: 25670083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic mutations in DROSHA and DICER1 impair microRNA biogenesis through distinct mechanisms in Wilms tumours.
    Rakheja D; Chen KS; Liu Y; Shukla AA; Schmid V; Chang TC; Khokhar S; Wickiser JE; Karandikar NJ; Malter JS; Mendell JT; Amatruda JF
    Nat Commun; 2014 Sep; 2():4802. PubMed ID: 25190313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The development of Wilms tumor: from WT1 and microRNA to animal models.
    Tian F; Yourek G; Shi X; Yang Y
    Biochim Biophys Acta; 2014 Aug; 1846(1):180-7. PubMed ID: 25018051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nephron Progenitor But Not Stromal Progenitor Cells Give Rise to Wilms Tumors in Mouse Models with β-Catenin Activation or Wt1 Ablation and Igf2 Upregulation.
    Huang L; Mokkapati S; Hu Q; Ruteshouser EC; Hicks MJ; Huff V
    Neoplasia; 2016 Feb; 18(2):71-81. PubMed ID: 26936393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The yin and yang of kidney development and Wilms' tumors.
    Hohenstein P; Pritchard-Jones K; Charlton J
    Genes Dev; 2015 Mar; 29(5):467-82. PubMed ID: 25737276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ARF tumor-suppressor controls Drosha translation to prevent Ras-driven transformation.
    Kuchenreuther MJ; Weber JD
    Oncogene; 2014 Jan; 33(3):300-7. PubMed ID: 23318441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of Dgcr8-mediated microRNA expression in the kidney results in hydronephrosis and renal malformation.
    Bartram MP; Dafinger C; Habbig S; Benzing T; Schermer B; Müller RU
    BMC Nephrol; 2015 Apr; 16():55. PubMed ID: 25881298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Children's Oncology Group and TARGET initiative exploring the genetic landscape of Wilms tumor.
    Gadd S; Huff V; Walz AL; Ooms AHAG; Armstrong AE; Gerhard DS; Smith MA; Auvil JMG; Meerzaman D; Chen QR; Hsu CH; Yan C; Nguyen C; Hu Y; Hermida LC; Davidsen T; Gesuwan P; Ma Y; Zong Z; Mungall AJ; Moore RA; Marra MA; Dome JS; Mullighan CG; Ma J; Wheeler DA; Hampton OA; Ross N; Gastier-Foster JM; Arold ST; Perlman EJ
    Nat Genet; 2017 Oct; 49(10):1487-1494. PubMed ID: 28825729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early postnatal ablation of the microRNA-processing enzyme, Drosha, causes chondrocyte death and impairs the structural integrity of the articular cartilage.
    Kobayashi T; Papaioannou G; Mirzamohammadi F; Kozhemyakina E; Zhang M; Blelloch R; Chong MW
    Osteoarthritis Cartilage; 2015 Jul; 23(7):1214-20. PubMed ID: 25707934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosomal anomalies at 1q, 3, 16q, and mutations of SIX1 and DROSHA genes underlie Wilms tumor recurrences.
    Spreafico F; Ciceri S; Gamba B; Torri F; Terenziani M; Collini P; Macciardi F; Radice P; Perotti D
    Oncotarget; 2016 Feb; 7(8):8908-15. PubMed ID: 26802027
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Cerqueira DM; Bodnar AJ; Phua YL; Freer R; Hemker SL; Walensky LD; Hukriede NA; Ho J
    FASEB J; 2017 Aug; 31(8):3540-3554. PubMed ID: 28446592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent DGCR8, DROSHA, and SIX homeodomain mutations in favorable histology Wilms tumors.
    Walz AL; Ooms A; Gadd S; Gerhard DS; Smith MA; Guidry Auvil JM; Meerzaman D; Chen QR; Hsu CH; Yan C; Nguyen C; Hu Y; Bowlby R; Brooks D; Ma Y; Mungall AJ; Moore RA; Schein J; Marra MA; Huff V; Dome JS; Chi YY; Mullighan CG; Ma J; Wheeler DA; Hampton OA; Jafari N; Ross N; Gastier-Foster JM; Perlman EJ
    Cancer Cell; 2015 Feb; 27(2):286-97. PubMed ID: 25670082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional regulatory control of mammalian nephron progenitors revealed by multi-factor cistromic analysis and genetic studies.
    O'Brien LL; Guo Q; Bahrami-Samani E; Park JS; Hasso SM; Lee YJ; Fang A; Kim AD; Guo J; Hong TM; Peterson KA; Lozanoff S; Raviram R; Ren B; Fogelgren B; Smith AD; Valouev A; McMahon AP
    PLoS Genet; 2018 Jan; 14(1):e1007181. PubMed ID: 29377931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wilms tumor and the WT1 gene.
    Lee SB; Haber DA
    Exp Cell Res; 2001 Mar; 264(1):74-99. PubMed ID: 11237525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wilms' tumour: connecting tumorigenesis and organ development in the kidney.
    Rivera MN; Haber DA
    Nat Rev Cancer; 2005 Sep; 5(9):699-712. PubMed ID: 16110318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two MicroRNAs Are Sufficient for Embryonic Patterning in C. elegans.
    Dexheimer PJ; Wang J; Cochella L
    Curr Biol; 2020 Dec; 30(24):5058-5065.e5. PubMed ID: 33125867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-483-5p Targets MKNK1 to Suppress Wilms' Tumor Cell Proliferation and Apoptosis In Vitro and In Vivo.
    Liu K; He B; Xu J; Li Y; Guo C; Cai Q; Wang S
    Med Sci Monit; 2019 Feb; 25():1459-1468. PubMed ID: 30798328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.